CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	1 Months Ended	11 Months Ended	12 Months Ended
	Jan. 31, 2015	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2014
Successor
Cash flows from operating activities
Net income		$ 268,299	$ 393,029
Adjustments to reconcile net income to net cash provided by operating activities:
Realized investment (gains) losses		163,882	(32,623)
Amortization of deferred policy acquisition costs and value of business acquired		94,056	149,064
Capitalization of deferred policy acquisition costs		(296,795)	(327,938)
Depreciation and amortization expense		49,741	37,504
Deferred income tax		130,072	247,687
Accrued income tax		65,415	(162,619)
Interest credited to universal life and investment products		682,836	699,227
Policy fees assessed on universal life and investment products		(1,056,092)	(1,262,166)
Change in reinsurance receivables		187,269	222,302
Change in accrued investment income and other receivables		24,202	(36,360)
Change in policy liabilities and other policyholders' funds of traditional life and health products		(164,232)	(208,075)
Trading securities:
Maturities and principal reductions of investments		114,501	154,633
Sale of investments		135,465	459,802
Cost of investments acquired		(220,094)	(532,429)
Other net change in trading securities		73,376	22,427
Amortization of premiums and accretion of discounts on investments and mortgage loans		373,636	375,044
Change in other liabilities		(206,765)	132,220
Other income—gains on repurchase of non-recourse funding obligations		0	0
Other, net		(63,144)	(81,091)
Net cash provided by operating activities		355,628	249,638
Cash flows from investing activities
Maturities and principal reductions of investments, available-for-sale		1,052,198	1,299,753
Sale of investments, available-for-sale		1,336,350	1,956,302
Cost of investments acquired, available-for-sale		(3,546,474)	(4,982,907)
Change in investments, held-to-maturity		(65,000)	(2,181,000)
Mortgage loans:
New lendings		(1,466,020)	(1,396,283)
Repayments		1,306,034	863,873
Change in investment real estate, net		(3,662)	2,851
Change in policy loans, net		52,364	49,268
Change in other long-term investments, net		(73,907)	(250,557)
Change in short-term investments, net		(11,221)	(72,810)
Net unsettled security transactions		(64,615)	28,853
Purchase of property and equipment		(8,862)	(5,295)
Sales of property and equipment		0	0
Cash received from or paid for acquisitions, net of cash acquired		0	320,967
Net cash (used in) provided by investing activities		(1,492,815)	(4,366,985)
Cash flows from financing activities
Borrowings under line of credit arrangements and debt		330,000	265,000
Principal payments on line of credit arrangement and debt		(338,093)	(633,074)
Issuance (repayment) of non-recourse funding obligations		65,000	2,094,700
Repurchase program borrowings		388,185	359,536
Dividends to shareowners		0	(89,343)
Withholdings of share-based payment arrangements settled in cash		0	0
Excess tax benefits from share-based payment arrangements		0	0
Investment product and universal life deposits		3,064,373	4,393,596
Investment product and universal life withdrawals		(2,438,916)	(2,320,958)
Other financing activities, net		0	0
Net cash provided by (used in) financing activities		1,070,549	4,069,457
Change in cash		(66,638)	(47,890)
Cash at beginning of period		462,710	396,072
Cash at end of period	$ 462,710	396,072	$ 348,182
Predecessor
Cash flows from operating activities
Net income	1,509			$ 384,875
Adjustments to reconcile net income to net cash provided by operating activities:
Realized investment (gains) losses	42,602			148,751
Amortization of deferred policy acquisition costs and value of business acquired	4,072			257,309
Capitalization of deferred policy acquisition costs	(22,489)			(288,532)
Depreciation and amortization expense	820			7,701
Deferred income tax	30,791			471
Accrued income tax	(32,803)			11,140
Interest credited to universal life and investment products	79,088			824,418
Policy fees assessed on universal life and investment products	(90,288)			(1,038,180)
Change in reinsurance receivables	(85,081)			69,002
Change in accrued investment income and other receivables	(5,789)			13,794
Change in policy liabilities and other policyholders' funds of traditional life and health products	176,980			102,524
Trading securities:
Maturities and principal reductions of investments	17,946			114,793
Sale of investments	26,422			353,250
Cost of investments acquired	(27,289)			(320,928)
Other net change in trading securities	(26,901)			(69,641)
Amortization of premiums and accretion of discounts on investments and mortgage loans	12,930			56,574
Change in other liabilities	238,592			180,717
Other income—gains on repurchase of non-recourse funding obligations	0			(10,480)
Other, net	(149,889)			(74,061)
Net cash provided by operating activities	191,223			723,497
Cash flows from investing activities
Maturities and principal reductions of investments, available-for-sale	59,028			1,198,690
Sale of investments, available-for-sale	191,062			2,271,611
Cost of investments acquired, available-for-sale	(149,887)			(3,603,567)
Change in investments, held-to-maturity	0			(70,000)
Mortgage loans:
New lendings	(100,530)			(925,910)
Repayments	45,741			1,285,489
Change in investment real estate, net	7			15,344
Change in policy loans, net	6,365			57,507
Change in other long-term investments, net	(25,339)			(87,580)
Change in short-term investments, net	(40,314)			(73,822)
Net unsettled security transactions	37,510			30,212
Purchase of property and equipment	(649)			(8,152)
Sales of property and equipment	0			0
Cash received from or paid for acquisitions, net of cash acquired	0			(906)
Net cash (used in) provided by investing activities	22,994			88,916
Cash flows from financing activities
Borrowings under line of credit arrangements and debt	0			500,000
Principal payments on line of credit arrangement and debt	(60,000)			(785,000)
Issuance (repayment) of non-recourse funding obligations	0			20,000
Repurchase program borrowings	0			(300,000)
Dividends to shareowners	0			(72,697)
Withholdings of share-based payment arrangements settled in cash	0			(32,173)
Excess tax benefits from share-based payment arrangements	0			20,948
Investment product and universal life deposits	169,233			2,576,727
Investment product and universal life withdrawals	(240,147)			(2,827,305)
Other financing activities, net	(4)			(44)
Net cash provided by (used in) financing activities	(130,918)			(899,544)
Change in cash	83,299			(87,131)
Cash at beginning of period	379,411	$ 462,710		466,542
Cash at end of period	$ 462,710			$ 379,411